Y-Intercept (HK)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.41M | Buy |
150,072
+142,423
| +1,862% | +$5.13M | 0.13% | 198 |
|
|
2025
Q1 | $238K | Buy |
+7,649
| New | +$238K | 0.02% | 990 |
|
|
2024
Q4 | – | Sell |
-30,853
| Closed | -$873K | – | 1589 |
|
|
2024
Q3 | $873K | Sell |
30,853
-7,200
| -19% | -$204K | 0.05% | 508 |
|
|
2024
Q2 | $1M | Buy |
38,053
+995
| +3% | +$26.2K | 0.06% | 488 |
|
|
2024
Q1 | $1.13M | Buy |
37,058
+26,354
| +246% | +$800K | 0.08% | 340 |
|
|
2023
Q4 | $301K | Sell |
10,704
-16,158
| -60% | -$454K | 0.03% | 822 |
|
|
2023
Q3 | $729K | Sell |
26,862
-21,149
| -44% | -$574K | 0.07% | 420 |
|
|
2023
Q2 | $1.48M | Buy |
+48,011
| New | +$1.48M | 0.16% | 168 |
|
|
2023
Q1 | – | Sell |
-16,076
| Closed | -$635K | – | 1482 |
|
|
2022
Q4 | $635K | Buy |
+16,076
| New | +$635K | 0.09% | 341 |
|
|
2021
Q1 | – | Sell |
-11,226
| Closed | -$555K | – | 773 |
|
|
2020
Q4 | $555K | Buy |
+11,226
| New | +$555K | 0.23% | 125 |
|